investment

News

Chiesi backs growth plans with a €430m new plant in Italy

Fast-growing pharma group Chiesi has revealed plans to spend €430m on a new therapeutics manufacturing facility at its site in Milan.

News

Building site with thre emen in high viz jackets and protective headweare

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

News

UK is becoming an 'outlier' for pharma, hitting investment

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

News

man in protective gear at manufacturing facility

MSD opens $1bn plant for HPV vaccine in the US

MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.

R&D

On incentivisation and investment in rare disease R&D

To mark Rare Disease Day, pharmaphorum spoke with Paola Pozzi, partner of telethon strategy at Sofinnova Partners, about the outlook for investment in this field of research.

R&D

Will 2025 be the year the pharmaceutical industry finds its ...

After spending 2024 in recovery mode, the biopharma industry is finally showing signs of growth, climbing back toward its pre-pandemic heights.

Chiesi backs growth plans with a €430m new plant in Italy

AZ builds in China, as J&J ramps up its US investments

UK is becoming an 'outlier' for pharma, hitting investment

MSD opens $1bn plant for HPV vaccine in the US

On incentivisation and investment in rare disease R&D

Will 2025 be the year the pharmaceutical industry finds its ...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

investment

Editor's Picks